These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12637244)

  • 1. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of ethosuximide by human hepatic microsomal enzymes.
    Bachmann K; He Y; Sarver JG; Peng N
    Xenobiotica; 2003 Mar; 33(3):265-76. PubMed ID: 12637244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.
    Wen X; Wang JS; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2002 Jan; 57(11):799-804. PubMed ID: 11868802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor.
    Tang C; Shou M; Mei Q; Rushmore TH; Rodrigues AD
    J Pharmacol Exp Ther; 2000 May; 293(2):453-9. PubMed ID: 10773015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
    Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
    Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of a novel phosphodiesterase-IV inhibitor (V11294) by human hepatic cytochrome P450 forms.
    Subrahmanyam V; Renwick AB; Walters DG; Price RJ; Tonelli AP; Lake BG
    Xenobiotica; 2002 Jun; 32(6):521-34. PubMed ID: 12160484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 isozymes 3A4 and 2B6 are involved in the in vitro human metabolism of thiotepa to TEPA.
    Jacobson PA; Green K; Birnbaum A; Remmel RP
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):461-7. PubMed ID: 12107550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily.
    Gorski JC; Jones DR; Wrighton SA; Hall SD
    Biochem Pharmacol; 1994 Jul; 48(1):173-82. PubMed ID: 8043020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of cytochrome P450 enzymes responsible for metabolism of cannabidiol by human liver microsomes.
    Jiang R; Yamaori S; Takeda S; Yamamoto I; Watanabe K
    Life Sci; 2011 Aug; 89(5-6):165-70. PubMed ID: 21704641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the cytochrome P450 isoenzymes involved in the in vitro N-dealkylation of haloperidol.
    Pan LP; Wijnant P; De Vriendt C; Rosseel MT; Belpaire FM
    Br J Clin Pharmacol; 1997 Dec; 44(6):557-64. PubMed ID: 9431831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
    Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
    Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5,6-dimethylxanthenone-4-acetic acid.
    Zhou S; Paxton JW; Tingle MD; Kestell P
    Drug Metab Dispos; 2000 Dec; 28(12):1449-56. PubMed ID: 11095582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethosuximide is primarily metabolized by CYP3A when incubated with isolated rat liver microsomes.
    Sarver JG; Bachmann KA; Zhu D; Klis WA
    Drug Metab Dispos; 1998 Jan; 26(1):78-82. PubMed ID: 9443857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the involvement of human liver microsomes CYP1A2 in the mono-hydroxylation of daidzein.
    Peng WX; Wang LS; Li HD; Abd El-Aty AM; Chen GL; Zhou HH
    Clin Chim Acta; 2003 Aug; 334(1-2):77-85. PubMed ID: 12867277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction.
    Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR
    Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of bromodichloromethane metabolism by cytochrome P450 isoenzymes in human liver microsomes.
    Zhao G; Allis JW
    Chem Biol Interact; 2002 May; 140(2):155-68. PubMed ID: 12076522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activation of o-phenylphenol to a major cytotoxic metabolite, phenylhydroquinone: role of human CYP1A2 and rat CYP2C11/CYP2E1.
    Ozawa S; Ohta K; Miyajima A; Kurebayashi H; Sunouchi M; Shimizu M; Murayama N; Matsumoto Y; Fukuoka M; Ohno Y
    Xenobiotica; 2000 Oct; 30(10):1005-17. PubMed ID: 11315102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-individual variability in the oxidation of 1,2-dibromoethane: use of heterologously expressed human cytochrome P450 and human liver microsomes.
    Wormhoudt LW; Ploemen JH; de Waziers I; Commandeur JN; Beaune PH; van Bladeren PJ; Vermeulen NP
    Chem Biol Interact; 1996 Sep; 101(3):175-92. PubMed ID: 8870687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of CYP3A4 as the principal enzyme catalyzing mifepristone (RU 486) oxidation in human liver microsomes.
    Jang GR; Wrighton SA; Benet LZ
    Biochem Pharmacol; 1996 Sep; 52(5):753-61. PubMed ID: 8765473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of inhibitory monoclonal antibodies to assess the contribution of cytochromes P450 to human drug metabolism.
    Shou M; Lu T; Krausz KW; Sai Y; Yang T; Korzekwa KR; Gonzalez FJ; Gelboin HV
    Eur J Pharmacol; 2000 Apr; 394(2-3):199-209. PubMed ID: 10771285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.